Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Stochastic is near the overbought zone, pointing to possible pullbacks as LLY moves toward the 1400 USD target
About ATTAIN-1 and ATTAIN-2 clinical trial program The ATTAIN Phase III global clinical development program for orforglipron has enrolled more than 4,500 people with obesity or overweight across two global registration trials
They are often temporary and manageable with a few simple strategies
Key Takeaways The dose math starts with vial identity
US$ 20.96
US$ 23.97
US$ 20.43
US$ 29.95
